We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (257)
- Legislation (84)
- COVID-19 (66)
- Compliance and enforcement (51)
- Vaping hub (46)
- Manufacturing (29)
- Import and export (22)
- Labelling and packaging (20)
- Medicinal cannabis hub (20)
- Scheduling (national classification system) (19)
- Safety monitoring and information (13)
- Weight loss products (6)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Committees and advisory bodies (2)
- Prescription opioids hub (2)
- Sunscreens (2)
- Unique Device Identification (UDI) hub (2)
- Clinical trials (1)
- Fees and payments (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
712 result(s) found, displaying 201 to 225
-
Regulatory decision noticesThis instrument is the Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine - Pfizer) (Tozinameran and Riltozinameran) Labelling Exemption 2022.
-
Media releasesThe TGA has issued one infringement notice to Queensland-based IMUNI Pty Ltd for allegedly advertising a complementary medicine for a therapeutic use that was not permitted.
-
Media releasesThe TGA has issued infringement notices for the alleged unlawful advertising of medicinal cannabis products on a website and through social media.
-
Media releasesThe TGA has issued infringement notices for the alleged unlawful advertising of medicinal cannabis products on their websites and social media platforms.
-
Media releasesThe TGA has provisionally approved Pfizer’s bivalent COVID-19 vaccine, tozinameran and riltozinameran (COMIRNATY Original/Omicron BA.1) for use as a booster dose in adults 18 years and over.
-
Media releasesOn 19 October 2022, the TGA provisionally approved Moderna's COVID-19 vaccine, SPIKEVAX (elasomeran), for use as a booster dose in individuals aged 12 years and older.
-
Media releasesInspire Cosmetology Pty Ltd fined $26,640 for alleged unlawful import of cosmetic injectable products
-
Media releasesNSW medical practitioner fined for allegedly illegally importing prescription medicines
-
Media releasesThe TGA has issued two infringement notices totalling $5,328 to a Queensland-based individual for the alleged unlawful use of a prohibited representation and endorsement in advertising a listed complementary medicine.
-
Media releasesThe TGA has granted a provisional determination to Moderna Australia Pty Ltd’s bivalent COVID-19 vaccine candidate: elasomeran and davesomeran (SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4/BA.5)
-
Media releasesThe TGA has provisionally approved a paediatric dose of Pfizer’s COVID-19 vaccine, COMIRNATY (tozinameran), for children aged 6 months to less than 5 years
-
Media releasesDirection and infringement notices given to MDNE Enterprises Pty Ltd for alleged unlawful advertising of nicotine vaping products
-
Regulatory decision noticesThe TGA has issued a direction notice to MDNE Enterprises Pty Ltd to cease promoting the use and supply of nicotine vaping products to the Australian public.
-
Media releasesBest Body Industries Pty Ltd fined for alleged unlawful advertising of sports supplements
-
Media releasesFines totalling $972,360 given to three medicinal cannabis companies for alleged unlawful advertising
-
Media releasesThe TGA has provisionally approved Pfizer's COVID-19 vaccine, COMIRNATY (tozinameran) for use as a booster dose in individuals 5 years to 11 years.
-
Media releasesJSHealth Vitamins Pty Ltd fined for alleged unlawful advertising
-
Media releasesThe TGA has published an independent expert report examining the incidence of serious injury and death from intentional paracetamol overdose.
-
Media releasesThe TGA has approved the first two nasal combination self-tests (for use at home) that detect both COVID-19 and influenza viral infections in humans.
-
Media releasesTGA approves asciminib and faricimab through the Access New Active Substance Work-Sharing Initiative
-
Regulatory decision noticesThis instrument is the Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine - Moderna) (Elasomeran and Imelasomeran) Labelling Exemption 2022.
-
Media releasesThe TGA has issued 7 infringement notices totalling $93,240 to Cyclotek Queensland Pty Ltd
-
Media releasesWA-based company World Environmental Technologies Pty Ltd fined $13,320 for alleged unlawful importation of ivermectin, a prescription-only medicine.
-
Media releasesTGA provisionally approves Moderna bivalent COVID-19 vaccine for use as a booster dose in adults
-
Regulatory decision noticesThe TGA has provisionally approved Moderna's bivalent COVID-19 vaccine, elasomeran/imelasomeran (SPIKEVAX Bivalent Original/Omicron) for use as a booster dose in adults 18 years and over.